Histone methylation regulation in neurodegenerative disorders

BS Basavarajappa, S Subbanna - International journal of molecular …, 2021 - mdpi.com
Advances achieved with molecular biology and genomics technologies have permitted
investigators to discover epigenetic mechanisms, such as DNA methylation and histone …

Alzheimer's disease-related epigenetic changes: novel therapeutic targets

A Paniri, MM Hosseini, H Akhavan-Niaki - Molecular Neurobiology, 2024 - Springer
Aging is a significant risk factor for Alzheimer's disease (AD), although the precise
mechanism and molecular basis of AD are not yet fully understood. Epigenetic mechanisms …

Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer's disease

Q Cao, W Wang, JB Williams, F Yang, ZJ Wang… - Science advances, 2020 - science.org
Epigenetic aberration is implicated in aging and neurodegeneration. Using postmortem
tissues from patients with Alzheimer's disease (AD) and AD mouse models, we have found …

Neuroepigenetics of ageing and neurodegeneration-associated dementia: an updated review

FA Mir, A Amanullah, BP Jain, Z Hyderi… - Ageing Research …, 2023 - Elsevier
Gene expression is tremendously altered in the brain during memory acquisition, recall, and
forgetfulness. However, non-genetic factors, including environmental elements, epigenetic …

One-carbon epigenetics and redox biology of neurodegeneration

F Coppedè - Free Radical Biology and Medicine, 2021 - Elsevier
One-carbon metabolism provides the methyl groups for both DNA and histone tail
methylation reactions, two of the main epigenetic processes that tightly regulate the …

Illuminating neural circuits in Alzheimer's disease

Y Ying, JZ Wang - Neuroscience Bulletin, 2021 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder and there is
currently no cure. Neural circuit dysfunction is the fundamental mechanism underlying the …

Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?

F Coppedè - Expert Opinion on Therapeutic Targets, 2021 - Taylor & Francis
Introduction: Alzheimer's disease (AD) is the most common neurodegenerative disorder and
the primary form of dementia in the elderly. Changes in DNA methylation and post …

Biological and therapeutic role of LSD1 in Alzheimer's diseases

Y Li, Y Zhao, X Li, L Zhai, H Zheng, Y Yan… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a common chronic neurodegenerative disease characterized by
cognitive learning and memory impairments, however, current treatments only provide …

AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets

L Ning, R Shen, B Xie, Y Jiang, X Geng… - … of Neuropathology & …, 2024 - academic.oup.com
Alzheimer disease (AD) is a prevalent neurodegenerative disorder that affects synapses and
leads to progressive cognitive decline. The role of N-methyl-D-aspartic acid (NMDA) …

A cytoplasmic form of EHMT1N methylates viral proteins to enable inclusion body maturation and efficient viral replication

KK Biligiri, NR Sharma, A Mohanty, DP Sarkar… - PLoS …, 2024 - journals.plos.org
Protein lysine methyltransferases (PKMTs) methylate histone and non-histone proteins to
regulate biological outcomes such as development and disease including viral infection …